Welcome to our dedicated page for Universal Ins Hldgs SEC filings (Ticker: UVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Universal Insurance Holdings, Inc. filings document formal disclosures for a property and casualty insurance holding company that writes personal residential homeowners insurance and performs related risk management, claims management and distribution services. Recent Form 8-K reports furnish quarterly and annual results, non-GAAP reconciliations, premium measures, book value, dividends and share repurchase authorization announcements.
The company's proxy materials cover annual meeting matters, director elections, executive compensation advisory votes and independent auditor ratification. Regulatory filings also record Regulation FD disclosures, exhibit press releases and Inline XBRL cover-page data associated with capital return announcements and operating results.
Universal Insurance Holdings (UVE): insider transaction reported. Executive Chairman and Director Sean P. Downes sold 20,000 shares of common stock on 10/29/2025 at a weighted average price of $31.4034. The sale occurred in multiple trades within a price range of $30.84 to $31.71.
Following this transaction, Downes beneficially owns 1,283,512 shares directly. He also reports indirect holdings of 18,000 shares by children and 2,000 shares by spouse.
Universal Insurance Holdings (UVE) — insider transaction filed. A company director reported a sale of common stock on 10/30/2025. The filing shows a disposition of 35,435 shares coded “S” for sale at a weighted average price of $31.4119.
Following the transaction, the reporting person beneficially owns 271,628 shares, held directly. The shares were sold in multiple trades within a price range of $31.13 to $31.625, and detailed trade‑by‑trade information is available upon request as noted in the footnote.
Universal Insurance Holdings (UVE) reported a profitable Q3 2025, with net income of $39.8 million after a loss in the prior year. Total revenues were $401.0 million as net premiums earned rose and losses and loss adjustment expenses fell to $252.3 million from $317.0 million a year ago. Diluted EPS was $1.38 (basic $1.43).
For the nine months, revenues reached $1.196 billion and net income was $116.4 million, reflecting stronger underwriting results and higher investment income. The balance sheet strengthened: stockholders’ equity increased to $495.0 million, cash and cash equivalents rose to $405.1 million, and restricted cash was $69.1 million. Unpaid losses declined to $682.6 million, aided by settlement of prior catastrophe claims. The company paid a $0.16 quarterly common dividend and continued share repurchases while maintaining $100.0 million of senior notes due 2026 and an undrawn $50.0 million revolving credit line. Shares outstanding were 28,048,881 as of October 27, 2025.
UVE filed a Form 144 notice for a proposed sale of 35,435 shares of common stock. The planned broker is Raymond James & Associates, and the filing lists an aggregate market value of $1,116,202.50. The approximate date of sale is 10/30/2025 on the NYSE.
The seller acquired these shares on 04/06/2018 in lieu of compensation from the issuer, with payment described as cash on the same date.
UVE filed a Form 144 notice for a proposed sale of 20,000 common shares with an aggregate market value $620,000, expected on 10/29/2025. The broker is Raymond James & Associates, and the shares are listed on the NYSE. Shares outstanding were 28,287,000.
The notice shows the securities to be sold were acquired on 03/13/2014 via Lieu Compensation from the issuer, with 110,309 shares acquired and cash listed as the nature of payment on that date.
Recent activity disclosed includes two sales of 20,000 shares each: on 08/04/2025 for $462,794.05 and on 09/04/2025 for $505,958.05.
Universal Insurance Holdings (UVE) furnished a press release announcing its financial results for the fiscal quarter ended September 30, 2025. The press release is attached as Exhibit 99.1.
The information, including Exhibit 99.1, is being furnished to the SEC and shall not be deemed “filed” under the Exchange Act or incorporated by reference unless specifically stated. The Form 8-K was signed by CFO Frank C. Wilcox on October 23, 2025.
Sean P. Downes, Executive Chairman and Director of Universal Insurance Holdings, Inc. (UVE), reported an insider sale on 09/04/2025. He disposed of 20,000 shares of common stock in multiple transactions at a weighted-average price of $25.3482, with individual trade prices ranging from $25.07 to $25.55.
After the sale Mr. Downes directly holds 1,303,512 shares. He also reports indirect holdings of 18,000 shares through his children and 2,000 shares through his spouse, implying total reported beneficial ownership of 1,323,512 shares when combining direct and indirect holdings disclosed on this Form 4.
Universal Insurance Hldg, Inc. (UVE) filer submitted a Form 144 reporting proposed and recent sales of common stock by an individual identified as Sean Downes. The notice lists a proposed sale of 20,000 shares through Raymond James & Associates with an aggregate market value of $465,000 and an approximate sale date of 09/04/2025 on the NYSE. The securities were reported as acquired on 08/12/2025 as "in lieu compensation" from the issuer, with payment noted as cash. The filing also discloses three sales in the past three months totaling 70,000 shares on 06/12/2025, 06/13/2025, and 08/04/2025 with gross proceeds of $671,524.05, $660,619.05, and $462,794.05 respectively. The signer certifies no undisclosed material adverse information.
Universal Insurance Holdings, Inc. reported that Donald Smith & Co., Inc. and affiliated DSCO Value Fund, L.P. together beneficially own 1,564,468 shares of common stock, representing 5.56% of the class. Donald Smith & Co., Inc. reports sole voting power over 1,439,765 shares and sole dispositive power over 1,549,505 shares, while DSCO Value Fund reports sole voting and dispositive power over 14,963 shares. The filing identifies Donald Smith & Co. as an investment adviser acting for institutional clients and states the reported holdings are held in the ordinary course of business, not to change or influence control of the issuer.